Breakthrough T1D

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

Jeffrey C. Barrett, David Clayton, Patrick Concannon et al. · Nature Genetics · 2009 · 1.8K citations · Full text

Genome-wide Association Study, Type 1, Loci Affect Risk +11

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal, Roy W. Beck, Kelly L. Close et al. · Diabetes Care · 2018 · 630 citations · Full text

New Term, Artificial Pancreas, Obesity +17

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Moshe Phillip, Revital Nimri, Richard M. Bergenstal et al. · Endocrine Reviews · 2022 · 364 citations · Full text

Biomedical Engineering, Artificial Pancreas, Aid Systems +16

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Manuela Battaglia, Simi Ahmed, Mark S. Anderson et al. · Diabetes Care · 2019 · 331 citations · Full text

Metabolic Syndrome, Disease Heterogeneity, Translational Medicine +15

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9